PSA testing: When it's useful, when it's not

Journal of Family Practice

Volumn 60, Issue 6, 2011, Pages 357-360

  Slatkoff, Susan ^a   Gamboa, Stephen ^a   Zolotor, Adam J ^a   Mounsey, Anne L ^a   Jones, Kohar ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CARDIOVASCULAR DISEASE; CASE REPORT; DIGITAL RECTAL EXAMINATION; ERECTILE DYSFUNCTION; FALSE POSITIVE RESULT; FOLLOW UP; HUMAN; HYPERTENSION; INTENTION TO TREAT ANALYSIS; MALE; MEDICAL DECISION MAKING; MEDICAL HISTORY; META ANALYSIS (TOPIC); NOTE; POST HOC ANALYSIS; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; URINE INCONTINENCE;

EID: 83455203691     PISSN: 00943509     EISSN: 15337294     Source Type: Journal    
DOI: None     Document Type: Note

References (12)

1. Djulbegovic M, Beyth RJ, Neuberger MM, et al. Screening for prostate cancer: systematic review and meta-analysis of randomized controlled trials. BMJ. 2010;341:c4543.
2. Crawford ED, Grubb R 3rd, Black A, et al. Comorbidity and mortality results from a randomized prostate cancer screening trial. J Clin Oncol. 2011;29:355-361.
3. American Cancer Society. Cancer facts & fi gures 2010. Atlanta, Ga: American Cancer Society; 2010. Available at: http://www. cancer.org/acs/groups/ content/@nho/documents/document/ acspc-024113.pdf. Accessed April 13, 2011.
4. American Cancer Society. Prostate cancer. Last medical review November 22, 2010. Available at: http://www.cancer.org/cancer/ prostatecancer/ detailedguide/prostate-cancer-key-statistics. Accessed April 13, 2011.
5. National Institutes of Health. Prostate cancer. Last updated February 14, 2011. Available at: http://report.nih.gov/NIHfactsheets/ ViewFactSheet.aspx? csid=60. Accessed May 9, 2011.
6. Lin K, Lipsitz R, Miller T, et al. Benefi ts and harms of prostatespecifi c antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:192-199.
7. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate- cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320-1328.
8. Andriole GL, Crawford ED, Grubb RL 3rd, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360:1310-1319.
9. Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA. 2000; 283:354-360. (Pubitemid 30051753)
10. Ilic D, O'Connor D, Greens, Wilt T. Screening for prostate cancer. Cochrane Database Syst Rev. 2006;(3):CD004720.
11. American Urological Association. Prostate-specifi c antigen best practice statement: 2009 update. Available at: http://www. auanet.org/content/ guidelines-and-quality-care/clinicalguidelines/ main-reports/psa09.pdf. Accessed March 16, 2011.
12. US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:185-191.